Starbucks Wins Delay Of Trial Over Cancer Risk In Coffee

Law360, Los Angeles (October 9, 2015, 9:22 PM EDT) -- Starbucks Corp. on Friday won a bid to stay a bench trial in California over whether its coffee poses a cancer risk and should be labeled accordingly under Proposition 65, as it seeks reversal of a ruling nixing its defense that a chemical present in its coffee is not at a level that would pose significant risk.

The suit, filed in 2010 by a nonprofit against Starbucks and dozens of other coffee purveyors, went to trial at the end of last year under a trifurcated plan that resulted in Starbucks losing its first-phase defense that the carcinogen acrylamide in coffee is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS